摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(S)-(-)-n-苯甲酰基-alpha-甲基苄胺 | 4108-58-1

中文名称
(S)-(-)-n-苯甲酰基-alpha-甲基苄胺
中文别名
(S)-N-苯甲酰基-1-苯乙胺
英文名称
(S)-N-(1-phenylethyl)benzamide
英文别名
N-(1-phenylethyl)benzamide;N-benzoyl-(-)-1-phenylethylamine;(S)-N-benzoyl-1-phenylethylamine;N-[(1S)-1-phenylethyl]benzamide
(S)-(-)-n-苯甲酰基-alpha-甲基苄胺化学式
CAS
4108-58-1
化学式
C15H15NO
mdl
MFCD03427638
分子量
225.29
InChiKey
FALTVGCCGMDSNZ-LBPRGKRZSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    119-121 °C
  • 稳定性/保质期:

    常温常压下,该物质是稳定的。

计算性质

  • 辛醇/水分配系数(LogP):
    3.1
  • 重原子数:
    17
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.133
  • 拓扑面积:
    29.1
  • 氢给体数:
    1
  • 氢受体数:
    1

安全信息

  • 安全说明:
    S24/25
  • 储存条件:
    密封保存,应储存在阴凉、干燥的仓库中。

SDS

SDS:d11c292a97aec1a7ea87aa7729726258
查看
Name: (S)-(-)-N-Benzoyl-alpha-Methylbenzylamine Material Safety Data Sheet
Synonym: N-[(1S)-1-Phenylethyl]benzamide
CAS: 4108-58-1
Section 1 - Chemical Product MSDS Name:(S)-(-)-N-Benzoyl-alpha-Methylbenzylamine Material Safety Data Sheet
Synonym:N-[(1S)-1-Phenylethyl]benzamide

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
CAS# Chemical Name content EINECS#
4108-58-1 (S)-(-)-N-Benzoyl-alpha-Methylbenzylam ca. 100 unlisted
Hazard Symbols: None Listed.
Risk Phrases: None Listed.

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
The toxicological properties of this material have not been fully investigated.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation.
Ingestion:
May cause irritation of the digestive tract. The toxicological properties of this substance have not been fully investigated.
Inhalation:
May cause respiratory tract irritation. The toxicological properties of this substance have not been fully investigated.
Chronic:
No information found.

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:
Treat symptomatically and supportively.

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container. Clean up spills immediately, observing precautions in the Protective Equipment section. Avoid generating dusty conditions.
Provide ventilation.

Section 7 - HANDLING and STORAGE
Handling:
Wash thoroughly after handling. Use with adequate ventilation.
Minimize dust generation and accumulation. Avoid breathing dust, vapor, mist, or gas. Avoid contact with eyes, skin, and clothing.
Keep container tightly closed. Avoid ingestion and inhalation.
Storage:
Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 4108-58-1: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Crystalline powder
Color: white
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 119 - 121 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water: Insoluble.
Specific Gravity/Density:
Molecular Formula: C15H15NO
Molecular Weight: 225.29

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable at room temperature in closed containers under normal storage and handling conditions.
Conditions to Avoid:
Incompatible materials, dust generation.
Incompatibilities with Other Materials:
Oxidizing agents.
Hazardous Decomposition Products:
Carbon monoxide, oxides of nitrogen, carbon dioxide.
Hazardous Polymerization: Will not occur.

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 4108-58-1 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
(S)-(-)-N-Benzoyl-alpha-Methylbenzylamine - Not listed by ACGIH, IARC, or NTP.

Section 12 - ECOLOGICAL INFORMATION


Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

Section 14 - TRANSPORT INFORMATION

IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
WGK (Water Danger/Protection)
CAS# 4108-58-1: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 4108-58-1 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 4108-58-1 is not listed on the TSCA inventory.
It is for research and development use only.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    (S)-(-)-n-苯甲酰基-alpha-甲基苄胺2-氟吡啶三氟甲磺酸酐 作用下, 以 二氯甲烷 为溶剂, 反应 3.0h, 以74%的产率得到苯甲腈
    参考文献:
    名称:
    脂族和芳族仲酰胺向腈的多功能和化学选择性转化
    摘要:
    三氟甲磺酸酐与2-氟吡啶结合可有效地使仲酰胺脱水,在温和的反应条件下提供腈。该反应是一般性的,并且与带有仲,叔或苄基N-烷基的脂族,α,β-不饱和,芳族和杂芳族酰胺的使用相容。该反应还显示出对仲酰胺的良好的化学选择性至优异的化学选择性,并能耐受几个不稳定的官能团。
    DOI:
    10.1016/j.tet.2015.03.094
  • 作为产物:
    描述:
    参考文献:
    名称:
    由手性β-胺化的有机锂中间体合成对映体纯的官能化酰胺(EPC合成)
    摘要:
    在-78°C下分别用正丁基锂和萘二甲酸锂连续进行手性氯酰胺1的去质子化反应,生成相应的手性β-胺化有机锂中间体2,该中间体通过与不同的亲电试剂[H 2 O,D 2 O中,Me 2小号2,(O,卜吨CHO和苯甲醛]产率,水解后,相应的对映体纯的化合物3。在使用醛作为亲电子试剂的情况下,获得了非对映异构体的混合物,其易于通过快速色谱法分离,因此对映体纯的1,3-氨基醇衍生物可通过该程序获得。
    DOI:
    10.1016/s0040-4039(00)76980-2
点击查看最新优质反应信息

文献信息

  • Regio- and Stereoselective (SN2) N-, O-, C- and S-Alkylation Using Trialkyl Phosphates
    作者:Amit Banerjee、Tomohiro Hattori、Hisashi Yamamoto
    DOI:10.1055/a-1504-8366
    日期:2023.1
    Bimolecular nucleophilic substitution (SN2) is one of the most well-known fundamental reactions in organic chemistry to generate new molecules from two molecules. In principle, a nucleophile attacks from the back side of an alkylating agent having a suitable leaving group, most commonly a halide. However, alkyl halides are expensive, very harmful, toxic and not so stable, which makes them problematic
    双分子亲核取代 (SN2) 是有机化学中最著名的基本反应之一,用于从两个分子生成新分子。原则上,亲核试剂从具有合适离去基团(最常见的是卤化物)的烷化剂的背面攻击。然而,烷基卤价格昂贵、非常有害、有毒且不稳定,这使得它们在实验室使用中存在问题。相比之下,磷酸三烷基酯价格低廉、易于获得且在室温、空气中稳定且易于处理,但很少用作有机合成中的烷基化剂。在这里,我们描述了一种使用现成的磷酸三烷基酯对各种 N-、O-、C- 和 S-亲核试剂进行亲核烷基化的温和、直接和强大的方法。反应以优异的收率顺利进行,和定量产量在许多情况下,并涵盖广泛的底物。此外,通过手性中心构型的反转(高达 98% ee)实现了仲烷基的罕见立体选择性转移。
  • [EN] PYRROLE COMPOUNDS FOR THE TREATMENT OF PROSTAGLANDIN MEDIATED DISEASES<br/>[FR] COMPOSES PYRROLIQUES DESTINES AU TRAITEMENT DE MALADIES INDUITES PAR PROSTAGLANDINE
    申请人:GLAXO GROUP LTD
    公开号:WO2003101959A1
    公开(公告)日:2003-12-11
    Compounds of formula (I) or a pharmaceutically acceptable derivative thereof: wherein A, R1, R2a, R2b, Rx, R8, and R9 are as defined in the specification, a process for the preparation of such compounds, pharmaceutical compositions comprising such compounds and the use of such compounds in medicine, in particular their use in the treatment of prostaglandin mediated diseases such as pain, inflammatory, immunological, bone, neurodegenerative or renal disorder.
    式(I)的化合物或其药学上可接受的衍生物:其中A、R1、R2a、R2b、Rx、R8和R9如规范中所定义,一种制备这种化合物的方法,包括这种化合物的药物组合物以及这种化合物在医学中的用途,特别是它们在治疗前列腺素介导的疾病,如疼痛、炎症、免疫、骨骼、神经退行性或肾脏疾病中的用途。
  • Combining Magnetic Resonance Spectroscopies, Mass Spectrometry, and Molecular Dynamics:  Investigation of Chiral Recognition by 2,6-di-<i>O</i>-Methyl-β-cyclodextrin
    作者:Paola Franchi、Marco Lucarini、Elisabetta Mezzina、Gian Franco Pedulli
    DOI:10.1021/ja049713y
    日期:2004.4.1
    the structurally related amine precursors of nitroxides. NOE data suggested that inclusion of the stereogenic center in the DM-beta-CD cavity occurs only when the R substituent linked to the chiral carbon contains an aromatic ring. For these types of complexes, molecular dynamics simulation indicated that the depth of penetration of the stereogenic center into the cyclodextrin cavity is determined by
    EPR 光谱已被用于研究 heptakis-(2,6-O-二甲基)-β-环糊精 (DM-β-CD) 和不同对映异构体对的通用结构 PhCH2NO.CH(R) 手性氮氧化物之间的复合物的形成R'。自由基和所含自由基浓度的准确平衡测量提供了这些氮氧化物的结合常数值。DM-β-CD 复合物的立体化学与复合热力学之间的关系通过将 EPR 数据与 1H-1H NOE 测量相关联,对 DM-β-CD 和结构相关的硝基氧胺前体之间的复合物进行了测量。NOE 数据表明,仅当与手性碳相连的 R 取代基包含芳香环时,才会在 DM-β-CD 腔中包含立体中心。对于这些类型的复合物,分子动力学模拟表明立体中心渗透到环糊精腔中的深度由不对称碳上的第二个取代基 (R') 的性质决定,并且是观察到的手性选择性的原因。质谱分析表明,对于目前研究的胺,通过 ESI-MS 检测到 CD 与质子化胺的静电外部加合物。
  • [EN] PIPERIDINETRIOL DERIVATIVES AS INHIBITORS OF GLYCOSYLCERAMIDE SYNTHASE<br/>[FR] UTILISATION DE DERIVES DU PIPERIDINETRIOL EN TANT QU'INHIBITEURS DE LA GLYCOSYLCERAMIDE SYNTHASE
    申请人:OXFORD GLYCOSCIENCES UK LTD
    公开号:WO2004007453A1
    公开(公告)日:2004-01-22
    Compounds of formula (I): wherein R represents various substituent groups, are useful as inhibitors of glucosylceramide synthase.
    式(I)的化合物:其中R代表各种取代基团,可用作葡萄糖酰胺合成酶的抑制剂
  • Simple Synthesis of Amides and Weinreb Amides Using PPh3 or Polymer-Supported PPh3 and Iodine
    作者:Amit Kumar、Hari Kiran Akula、Mahesh K. Lakshman
    DOI:10.1002/ejoc.200901420
    日期:2010.5
    range of carboxylic acids to 2 degrees , 3 degrees , and Weinreb amides. Simplification of the procedure was possible with the use of polymer-supported PPh3/I2. Weinreb amides produced via the use of polymer-supported PPh3 could be filtered through a short silica gel plug and used in further transformations. Thus, use of polymer-supported PPh3 offers potential applicability to diversity-oriented reactions
    已经证明,PPh 3 / I 2的组合对于将一系列羧酸转化为2度,3度和Weinreb酰胺是有效的。使用聚合物负载的PPh3 / I2可以简化程序。通过使用聚合物负载的PPh3制备的Weinreb酰胺可以通过短硅胶塞过滤,并用于进一步的转化。因此,使用聚合物负载的PPh3可为面向多样性的反应提供潜在的适用性。通过使用这种酰胺形成方法,已经完成了载脂蛋白和普拉托恩的正式全部合成,以及脱胆碱酮和马来帕定的合成。已尝试获得对该反应的了解。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫